Nousiainen,T

Institution: ESiOR Oy, Kuopio, Finland

Research Interests: Patients, Cost, Lymphoma, Maintenance, Treatment, Blood, Cell, Cells, Patient, Stem, Stem Cell, Stem Cells, Costs, Cyclophosphamide, Doxorubicin, Health, Health Care, Hodgkins Lymphoma, Life, Non-hodgkins Lymphoma